Filter Results
:
(21)
Show Results For
-
All HBS Web
(113,907)
- Faculty Publications (21)
Show Results For
-
All HBS Web
(113,907)
- Faculty Publications (21)
Page 1 of
21
Results
→
- October 2023
- Case
TetraScience: Unlocking the Power of Scientific Data
By: Satish Tadikonda and William Marks
- October 2023
- Case
Thermo Fisher Scientific: Foray Into Contract Research
By: Satish Tadikonda, William Marks and Kevin Emancipator
- October 2023
- Case
Catalent: Catalyzing the Next Era of Growth
By: Satish Tadikonda, William Marks and Kevin Emancipator
- October 2023
- Case
Revvity: A Symbol of Change
By: Satish Tadikonda and William Marks
Tadikonda, Satish, and William Marks. "Revvity: A Symbol of Change." Harvard Business School Case 824-071, October 2023.
- September 2023
- Case
THREAD Research: Decentralized Clinical Trials and Beyond
By: Satish Tadikonda, Amanda McEwen and William Marks
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
- August 2023 (Revised September 2023)
- Case
Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
- August 2023
- Background Note
A Note on the Differences Between Therapeutics, Medical Devices, and Diagnostics
By: Satish Tadikonda, Ananya Zutshi, Hunter Goble and William Marks
Tadikonda, Satish, Ananya Zutshi, Hunter Goble, and William Marks. "A Note on the Differences Between Therapeutics, Medical Devices, and Diagnostics." Harvard Business School Background Note 824-045, August 2023.
- August 2023
- Teaching Note
Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
- August 2023
- Case
Morphic Therapeutic: Making the Initial Pipeline Decisions
By: Satish Tadikonda and Ananya Zutshi
- August 2023
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda and Olivia Reszczynski
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still...
View Details
Tadikonda, Satish, and Olivia Reszczynski. "Sky Therapeutics: Innovating in Digital Therapeutics." Harvard Business School Case 824-023, August 2023.
- July 2023
- Case
HealthVerity: Real World Data and Evidence
By: Satish Tadikonda
Andrew Kress (CEO and founder) and his team had built a promising marketplace business at HealthVerity serving its core market in healthcare, with a focus on pharmaceutical R&D and services. Thus far, HealthVerity’s products had been unique to the pharma and pharma...
View Details
Tadikonda, Satish. "HealthVerity: Real World Data and Evidence." Harvard Business School Case 824-019, July 2023.
- July 2023 (Revised July 2023)
- Case
Miracle Therapeutics (A): Negotiating an IP License
By: Satish Tadikonda, Michael Singer, William Marks and Wendi Yajnik
- July 2023
- Case
Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks